NEW YORK, Jan. 15, 2018 /PRNewswire/ -- The global market for research antibodies is expected to grow to $3.0 billion by 2022 from $2.4 billion in 2017 at a compound annual growth rate (CAGR) of 4.8% from 2017 to 2022. Read the full report: https://www.reportlinker.com/p02669411
• The US market for research antibodies is expected to grow from $943 million in 2017 to $1.1 billion in 2022 at a CAGR of 3.4% for the period 2017-2022. • Asia-Pacific market for research antibodies is expected to grow from $593 million in 2017 to $830 million in 2022 at a CAGR of 7.0% for the period 2017-2022. Chapter 1: Introduction
Study Goals and Objectives
The aim of this report is to provide detailed market and industry analyses to help readers quantify and qualify the global market for research antibodies. Important trends in the field and market segments are identified, and market sizes and sales forecasts by segmented markets are provided through 2022. This report focuses on the market side rather than the technical side. The detailed market segmentation, market shares, major drivers, trend analysis and forecasts for the entire research antibody market are analyzed. In particular, this report includes:
• An overview of the global market for antibodies used in research. • Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022. • Segmentation of the market by geography, product type, research application, species and major research area. • Details concerning end users, purchasing factors, new market trends and potential growth opportunities. • Discussion of the factors affecting strategies of antibody companies, the effect of research funding and third-party quality evaluation systems. • Analysis of the competitive landscape and market shares for the key players. • Comprehensive company profiles of the major players in the research antibody field. Reasons for Doing This Study
Detailed market and industry analysis for the research antibody market is needed. The research antibody market reports available are more focused on analysis of end users' surveys, customer needs and the overall antibody market. There is no detailed market segmentation and trend analysis for each market segment. In fact, the research antibody industry is also at a critical time for a revolutionary or breakthrough change. New technologies for antibody generations are emerging, and new research needs, including those for new targets, higher specificity and higher sensitivity, etc., are increasing. More importantly, improving scientific reproducibility, including improving the lot-to-lot consistency of research reagents such as antibodies, is being emphasized by all related communities. Those antibody suppliers who hold proprietary technologies in making antibodies with the lot-to-lot consistency will probably be able to better meet the market needs. So, will the research antibody market stick with the current situation or will a breakthrough occur in the next five to ten years? Are there still any opportunities for new entries in a market that has been crowded with hundreds of big and small suppliers? How much will the current competitive landscape of the research antibody market change over the next five years? This report will provide useful information, analysis and forecasts to help you find the answers to these questions. Since the first generation of monoclonal antibodies in 1975, the antibody industry has evolved to a prosperous one today. The research sector of the antibody industry is the smallest of the three sectors of the antibody industry, the other two being the diagnostic and therapeutic sectors. However, the research antibody sector is a foundation of the other two. To some degree, detailed analysis of research sectors will also bring about some key hints in the market directions of the diagnostic and therapeutic sectors. The information in this report can help all antibody suppliers better understand the overall antibody market and the segment of the market they focus on. The detailed analysis and forecasts of the research antibody market can provide useful information for all management levels to help make strategic decisions in related areas. Intended Audience This report is designed to meet the information needs of various individuals involved in the biological research, pharmaceutical and medical research marketplaces, including company senior management executives seeking to base their strategic decisions on the best available information on market forces and trends. It is also aimed at managers and executives in marketing, research, planning and sales departments who need readable, comprehensive and up-to-date background on the marketplaces associated with the research antibodies with which they are operating. This report was prepared as a study of the global market for research antibodies. Information is presented with a specific focus on the various market segments, including geography, application, technological method, product-type and product function. The detailed segmentation will provide an indepth profile of the global research antibodies market, from which the market forecasts can be made. This study will be of significant interest to academic institutions, hospitals, biotech and pharmaceutical companies, biopharmaceutical researchers, marketing executives from pharmaceutical and biotech companies, contract research organizations (CROs), biologists, chemists, physicians, pharmaceutical directors, product managers and representatives, and all manner of institutional directors from either public or private entities. It will also be of interest to investment bankers in the biotechnology and pharmaceutical sectors, insurance executives and life sciences product marketing managers. Scope of Report
This study focuses on the market side of research antibodies rather than the technical side. Different market segments for this specific market are covered. For example, application-based market segments include enzyme-linked immunosorbent assay (ELISA), western blotting (WB), immunohistochemistry (IHC), immunofluorescent staining (IF) and flow cytometry (FC); antibody function-based market segments include primary antibodies and secondary antibodies; antibody clonality-based market segments include polyclonal antibodies and monoclonal antibodies, including oligoclonal antibodies; customer type-based market segments include universities/academic institutions, pharmaceutical/ biotech companies and other types of customers such as governmental research labs and CROs; geography-based market segments include the U.S., Europe, Asia-Pacific and Rest of World. Research and market trends are also extrapolated by analyzing the funding, patent publications and sales trends of major players in the field. Information Sources
Information sources included marketing strategists, industry executives, academic experts, government agencies and regulatory bodies, and surveys of scientists in both academic and industrial areas. Company annual reports and Securities and Exchange Commission (SEC) filings, journal articles, newsletters, expert blogs and data from related institutions were also reviewed. Methodology
Both primary and secondary research methodologies were used to prepare this study. Primary research includes interviews with leading individuals in research antibody companies and industry associations. Primary sources of published data include company annual reports, SEC filings, and government and industry publications. Secondary sources consist of literature searches, industry journals and other commercial publications. Data for market estimates and forecasts are pooled from a range of sources that were critically assessed by BCC Research. Geographic Breakdown
In this report, the geographic regions considered for market analysis include, and only include:
• United States. • Europe. • Asia-Pacific. • Rest of World. Global Market for Research Antibodies, by Application
ELISA Western Blotting IF/ICC Flow Cytometry Immunohistochemistry Global Market for Research Antibodies, by End User
Universities/ Academic Institutions Pharma/Biotech companies Others Global Market for Research Antibodies, by Type
Primary Antibodies Secondary Antibodies Global Market for Research Antibodies, by Type
Polyclonal Antibodies Monoclonal Antibodies Global Market for Research Antibodies, by Type
Unconjugated Antibodies Conjugated Antibodies Chapter 2: Summary and Highlights
The global market for research antibodies was estimated at about $2.3 billion in 2016, and is expected $3.0 billion in 2022, growing at a compound annual growth rate (CAGR) of 4.8% during the forecast period from 2017 to 2022. All regional markets will experience growth but at different rates. The strong R&D investment in the Asia-Pacific market will bring about the most rapid growth of the research antibody market in this region. The U.S. market, which accounted for about 40% of the global research antibody market in 2016, will continue to be impacted by cuts in research funding and will therefore grow at an estimated CAGR of 3.4% from 2017 through 2022. Although it appears that the overall research antibody market is relatively stable in terms of the overall market size, a dramatic change in the leading antibody manufacturing technologies, including significantly enhanced validation technologies product attributes and competitive landscape, is anticipated in next few years. In other words, the market growth in research antibodies is expected to be more focused on "content" than "volume" in next three to five years. Key Drivers for Market Growth This report has identified several key drivers for the growth and changes in the research antibody market, including:
• New discoveries in biological sciences. • New antibody manufacturing technologies and new antibody types. • The success of antibody-drug conjugate, which will lead to more antibody-related or antibody- focused research activities. • Antibody-based drug discovery and development. • Increased government funding, particularly in emerging markets. • Need for further human genomic and proteomic research. • Need for quality antibodies in the current research community. • New application-focused technology platforms such as Simple Western from ProteinSimple and Mass Cytometry from Fluidigm. • "Hot" research areas such as stem cell research, genome editing, exosome biology, epigenetics, neuroscience and cancer research. • Enhanced antibody validation will improve and potentially increase the antibody uses. This report identifies key revenue segments for the research antibody market from various aspects. Application-based market segments include enzyme-linked immunosorbent assay (ELISA), western blotting (WB), immunohistochemistry (IHC), immunofluorescent staining (IF) and flow cytometry (FC); antibody function-based market segments include primary antibodies and secondary antibodies; antibody clonality-based market segments include polyclonal antibodies and monoclonal antibodies including oligoclonal antibodies; customer type-based market segments include universities/academic institutions, pharmaceutical/biotech companies and other types of customers, such as governmental research labs and CROs, etc.; and geography-based market segments include the U.S., Europe, AsiaPacific and Rest of World. In recent years, custom services have also become an important part of the research antibody market. Custom services include custom production of polyclonal or monoclonal antibodies, antibody conjugation, labeling, antigen preparation, etc. In particular, new antibody production technologies, such as the use of DNA as an antigen, recombinant antibody technology and rabbit monoclonal antibody technology, are becoming major drivers of the research antibody services market. This report provides an overview of the global market for antibodies used in research, including the analyses of global market trends, with data from 2016, estimates for 2017, and projections of CAGRs through 2022, and the segmentation of the market by geography, product types, research applications and species, etc. The report also discusses customer needs and purchasing factors from different types of end users and decision makers, and analyzes new market trends and potential growth opportunities, including the factors affecting the strategies of the antibody companies, the effect of research funding, third-party quality evaluation systems, and recent merger and acquisition activities. The competitive landscape for the next few years is also described, including the key players' market shares and comprehensive company profiles of the major players in the research antibody field. Read the full report: https://www.reportlinker.com/p02669411
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: [email protected]
US: (646)-751-7922 Intl: +1 646-751-7922
Advertisement
View original content:http://www.prnewswire.com/news-releases/the-global-market-for-research-antibodies-is-expected-to-grow-to-30-billion-by-2022-from-24-billion-in-2017-at-a-compound-annual-growth-rate-cagr-of-48-from-2017-to-2022-300582727.html
SOURCE Reportlinker
